A retrospective, single-center study of glasdegib + Cytarabine in relapsed or refractory acute myeloid leukemia in unfit patients
Latest Information Update: 11 May 2021
At a glance
- Drugs Cytarabine (Primary) ; Glasdegib (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 11 May 2021 New trial record
- 01 May 2021 Results published in the Annals of Hematology